Bridgeway Capital Management’s Kodiak Sciences KOD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.59M Buy
40,700
+22,500
+124% +$875K 0.03% 629
2026
Q1
$694K Sell
18,200
-25,000
-58% -$646K 0.01% 771
2025
Q4
$1.21M Sell
43,200
-29,000
-40% -$594K 0.03% 668
2025
Q3
$1.18M Sell
72,200
-29,700
-29% -$256K 0.03% 672
2025
Q2
$380K Buy
101,900
+7,700
+8% +$27.3K 0.01% 820
2025
Q1
$264K Sell
94,200
-45,000
-32% -$245K 0.01% 863
2024
Q4
$1.39M Hold
139,200
0.03% 599
2024
Q3
$363K Hold
139,200
0.01% 933
2024
Q2
$327K Buy
139,200
+25,000
+22% +$84.7K 0.01% 954
2024
Q1
$601K Hold
114,200
0.01% 876
2023
Q4
$347K Buy
+114,200
New +$254K 0.01% 1038
2020
Q1
Sell
-10,000
Closed -$720K 1320
2019
Q4
$720K Sell
10,000
-2,500
-20% -$91K 0.01% 829
2019
Q3
$180K Hold
12,500
﹤0.01% 1197
2019
Q2
$146K Buy
+12,500
New +$111K ﹤0.01% 1219

Other funds holding KOD

Bridgeway Capital Management's KOD Position: Q2 2026 in Review

Bridgeway Capital Management increased its Kodiak Sciences (KOD) stake by 124% in Q2 2026, buying an estimated $875K and bringing the position to 40,700 shares worth $1.59M. The position accounts for 0.03% of the portfolio, ranked #629.

Bridgeway Capital Management first reported a position in KOD in Q2 2019 and has held it in 14 quarters since. 201 funds tracked by Wall St. Rank hold KOD as of Q2 2026.

  • Bridgeway Capital Management held 40,700 shares of Kodiak Sciences worth $1.59M as of Q2 2026.
  • Bridgeway Capital Management bought 22,500 Kodiak Sciences shares in Q2 2026, an estimated $875K.
  • Kodiak Sciences made up 0.03% of Bridgeway Capital Management's portfolio in Q2 2026, its #629 holding.
  • Bridgeway Capital Management first reported a position in Kodiak Sciences in Q2 2019 and has held it in 14 quarters since.
  • 201 funds tracked by Wall St. Rank held Kodiak Sciences as of Q2 2026.

Based on Bridgeway Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.